ENDP
$15.68
Endo Int'l Plc
($.12)
(.76%)

Earnings History

Earnings
Revenue
Reaction
Drift
EPS Below Estimates
FY 2012
2/24/2012
7:00:00 AM
$5.00 to $5.20
3.7%
6.2%
Guidance:
Consensus:
Endo Pharmaceuticals Sees Earnings Below Estimates

Endo Pharmaceuticals Holdings Inc. said it expects 2012 non-GAAP earnings of $5.00 to $5.20 per share on revenue of $3.15 billion to $3.30 billion. The current consensus earnings estimate is $5.46 per share on revenue of $3.23 billion for the year ending December 31, 2012.
Lowers Guidance In-line with Estimates
FY 2012
8/7/2012
7:00:00 AM
$5.00 to $5.20
$3.05 bil to $3.175 bil
$5.02
$3.17 bil
3.0%
4.3%
Guidance:
Consensus:
Endo Pharmaceuticals Lowers Revenue Guidance,, but Remains In-line with Estimates

Endo Pharmaceuticals Holdings Inc. said it continues to expect 2012 earnings of $5.00 to $5.20 per share and now expects revenue of $3.05 billion to $3.175 billion. The company's previous guidance was revenue of $3.15 billion to $3.30 billion and the current consensus earnings estimate is $5.02 per share on revenue of $3.17 billion for the year ending December 31, 2012.
Narrows Guidance
FY 2012
11/5/2012
7:00:00 AM
$5.00 to $5.10
$3.05 bil
$5.02
$3.11 bil
-8.6%
-7.5%
Guidance:
Consensus:
Endo Pharmaceuticals Narrows Guidance Lower, but Earnings Remain In-line with Estimates

Endo Pharmaceuticals Holdings Inc. said it now expects 2012 earnings of $5.00 to $5.10 per share on revenue of approximately $3.05 billion. The company's previous guidance was earnings of $5.00 to $5.20 per share and now expects revenue of $3.05 billion to $3.175 billion and the current consensus earnings estimate is $5.02 per share on revenue of $3.11 billion for the year ending December 31, 2012.
EPS & Revenue Below Estimates
FY 2013
12/12/2012
5:25:00 PM
up to $5.20
-3.4%
-0.8%
Guidance:
Consensus:
Endo Pharmaceuticals Lowers Outlook

Endo Pharmaceuticals Holdings Inc. said it now expects 2012 earnings to be at or below the low-end of its previous guidance range of $5.00 to $5.10 per share. The current consensus earnings estimate is $5.01 per share for the year ending December 31, 2012. The company also said it expects 2013 results to fall short of its previous guidance for earnings of $5.20 to $5.40 per share on revenue of $3.00 billion to $3.20 billion. The current consensus earnings estimate is $5.22 per share on revenue of $3.08 billion for the year ending December 31, 2013.
EPS & Revenue Below Estimates
FY 2013
1/3/2013
4:30:00 PM
$4.40 to $4.70
-4.5%
3.4%
Guidance:
Consensus:
Endo Pharmaceuticals Guides Below 2013 Estimates

Endo Pharmaceuticals Holdings Inc. said it continues to expect 2012 earnings to be at or below the low-end of its earlier guidance range of $5.00 to $5.10 per share. The current consensus earnings estimate is $4.99 per share for the year ending December 31, 2012. The company also said it expects 2013 earnings of $4.40 to $4.70 per share on revenue of $2.80 billion to $2.95 billion. The current consensus earnings estimate is $5.02 per share on revenue of $3.05 billion for the year ending December 31, 2013.
Reaffirms
FY 2013
2/28/2013
4:06:00 PM
$4.40 to $4.70
-3.2%
2.2%
Guidance:
Consensus:
Endo Pharmaceuticals Reaffirms

Endo Pharmaceuticals Holdings Inc. said it continues to expect 2013 earnings of $4.40 to $4.70 per share on revenue of $2.80 billion to $2.95 billion. The current consensus earnings estimate is $4.56 per share on revenue of $2.91 billion for the year ending December 31, 2013.
Lowers Guidance In-line with Estimates
FY 2013
6/5/2013
4:15:00 PM
$4.10 to $4.40
$2.65 bil to $2.80 bil
$4.32
$2.80 bil
4.3%
5.5%
Guidance:
Consensus:
Endo Pharmaceuticals Lowers Guidance to be In-line with Estimates

Endo Pharmaceuticals Holdings Inc. said it expects 2013 earnings of $4.10 to $4.40 per share on revenue of $2.65 billion to $2.80 billion. The company's previous guidance was earnings of $4.40 to $4.70 per share on revenue of $2.80 billion to $2.95 billion and the current consensus earnings estimate is $4.32 per share on revenue of $2.80 billion for the year ending December 31, 2013.
Raises Guidance In-line with Estimates
FY 2013
8/6/2013
7:30:00 AM
$4.25 to $4.55
$2.70 bil to $2.80 bil
$4.35
$2.74 bil
-3.2%
-7.5%
Guidance:
Consensus:
Endo Pharmaceuticals Raises Guidance, but Remains In-line with Estimates

Endo Pharmaceuticals Holdings Inc. said it now expects 2013 earnings of $4.25 to $4.55 per share on revenue of $2.70 billion to $2.80 billion. The company's previous guidance was earnings of $4.10 to $4.40 per share on revenue of $2.65 billion to $2.80 billion and the current consensus earnings estimate is $4.35 per share on revenue of $2.74 billion for the year ending December 31, 2013.
Raises Guidance
FY 2013
11/5/2013
6:32:00 AM
$4.60 to $4.75
$2.75 bil to $2.80 bil
$4.57
$2.80 bil
28.8%
18.8%
Guidance:
Consensus:
Endo Health Solutions Raises Earnings Guidance Above Estimates

Endo Health Solutions said it expects 2013 earnings of $4.60 to $4.75 per share on revenue of $2.75 billion to $2.80 billion. The company's previous guidance was earnings of $4.25 to $4.55 per share on revenue of $2.70 billion to $2.80 billion and the current consensus earnings estimate is $4.57 per share on revenue of $2.80 billion for the year ending December 31, 2013.
EPS & Revenue Below Estimates
FY 2014
2/28/2014
6:00:00 AM
$3.40 to $3.65
-2.0%
-7.8%
Guidance:
Consensus:
Endo Health Solutions Sees 2014 Below Estimates

Endo Health Solutions said it expects 2014 earnings of $3.40 to $3.65 per share on revenue of $2.50 billion to $2.62 billion. The current consensus earnings estimate is $3.90 per share on revenue of $2.63 billion for the year ending December 31, 2014.
EPS & Revenue Above Estimates
FY 2014
5/1/2014
6:00:00 AM
$3.60 to $3.85
$2.55 bil to $2.64 bil
$3.51
$2.60 bil
5.4%
0.7%
Guidance:
Consensus:
Endo Health Solutions Raises Guidance

Endo Health Solutions said it expects 2014 earnings of $3.60 to $3.85 per share on revenue of $2.55 billion to $2.64 billion. The company's previous guidance was earnings of $3.40 to $3.65 per share on revenue of $2.50 billion to $2.62 billion and the current consensus earnings estimate is $3.51 per share on revenue of $2.60 billion for the year ending December 31, 2014.
EPS & Revenue Above Estimates
FY 2014
7/31/2014
6:30:00 AM
$3.80 to $4.00
$2.72 bil to $2.80 bil
$3.75
$2.61 bil
-1.0%
-10.6%
Guidance:
Consensus:
Endo Raises Guidance

Endo Health Solutions said it expects 2014 earnings of $3.80 to $4.00 per share on revenue of $2.72 billion to $2.80 billion. The company's previous guidance was earnings of $3.60 to $3.85 per share on revenue of $2.55 billion to $2.64 billion and the current consensus earnings estimate is $3.75 per share on revenue of $2.61 billion for the year ending December 31, 2014.
Raises Guidance In-line with Estimates
FY 2014
11/5/2014
7:00:00 AM
$4.10 to $4.25
$2.80 bil to $2.88 bil
$4.10
$2.81 bil
0.0%
-3.1%
Guidance:
Consensus:
Endo Raises Guidance to be In-line with Estimates

Endo Health Solutions said it expects 2014 earnings of $4.10 to $4.25 per share on revenue of $2.80 billion to $2.88 billion. The company's previous guidance was earnings of $3.80 to $4.00 per share on revenue of $2.72 billion to $2.80 billion and the current consensus earnings estimate is $4.10 per share on revenue of $2.81 billion for the year ending December 31, 2014.
EPS & Revenue Below Estimates
FY 2015
3/2/2015
7:00:00 AM
$4.35 to $4.55
2.0%
2.3%
Guidance:
Consensus:
Endo Guides Below Estimates

Endo International plc said it expects 2015 earnings of $4.35 to $4.55 per share on revenue of $2.90 billion to $3.00 billion. The current consensus earnings estimate is $4.87 per share on revenue of $3.47 billion for the year ending December 31, 2015.
Reaffirms
FY 2015
8/10/2015
6:30:00 AM
$4.40 to $4.60
$2.90 bil to $3.00 bil
$4.49
$2.99 bil
0.5%
7.6%
Guidance:
Consensus:
Endo International Reaffirms

Endo International plc said it continues to expect 2015 earnings of $4.40 to $4.60 per share on revenue of $2.90 billion to $3.00 billion. The current consensus earnings estimate is $4.49 per share on revenue of $2.99 billion for the year ending December 31, 2015.
EPS Above Estimates After Acquisition
FY 2016
9/28/2015
6:30:00 AM
$5.85 to $6.15
-10.2%
-1.9%
Guidance:
Consensus:
Endo International Sees 2016 Above Estimates with Acquisition

Endo International plc said it expects third quarter revenue of $720.0 million to $740.0 million. The current consensus revenue estimate is $754.1 million for the quarter ending September 30, 2015. However, the company said it continues to expect 2015 earnings of $4.50 to $4.60 per share and now expects revenue of $3.22 billion to $3.27 billion. The company's previous guidance was revenue of $2.90 billion to $3.00 billion and the current consensus earnings estimate is $4.47 per share on revenue of $2.96 billion for the year ending December 31, 2015. The company also said with its acquisition of Par it expects 2016 earnings of $5.85 to $6.15 per share. The current consensus earnings estimate is $5.48 per share for the year ending December 31, 2016.
EPS In-line/Revenue Below
FY 2016
2/29/2016
6:30:00 AM
$5.85 to $6.20
-21.0%
-11.7%
Guidance:
Consensus:
Endo Sees Revenue Below Estimates

Endo International plc said it expects 2016 earnings of $5.85 to $6.20 per share on revenue of $4.32 billion to $4.52 billion. The current consensus earnings estimate is $5.98 per share on revenue of $4.67 billion for the year ending December 31, 2016.
EPS & Revenue Below Estimates
FY 2016
5/5/2016
4:05:00 PM
$4.50 to $4.80
$3.87 bil to $4.03 bil
$5.76
$4.32 bil
-39.2%
-19.3%
Guidance:
Consensus:
Endo Lowers Guidance

Endo International plc said it expects 2016 earnings of $4.50 to $4.80 per share on revenue of $3.87 billion to $4.03 billion. The company's previous guidance was earnings of $5.85 to $6.20 per share on revenue of $4.32 billion to $4.52 billion and the current consensus earnings estimate is $5.76 per share on revenue of $4.32 billion for the year ending December 31, 2016.
EPS In-line
FY 2016
8/8/2016
4:28:00 PM
$4.50 to $4.80
$3.87 bil to $4.03 bil
$4.55
$3.93 bil
21.8%
13.1%
Guidance:
Consensus:
Endo Reaffirms

Endo International plc said it continues to expect 2016 earnings of $4.50 to $4.80 per share on revenue of $3.87 billion to $4.03 billion. The current consensus earnings estimate is $4.55 per share on revenue of $3.93 billion for the year ending December 31, 2016.
Reaffirms
FY 2016
11/8/2016
6:30:00 AM
$4.50 to $4.80
$3.87 bil to $4.03 bil
$4.55
$3.91 bil
-7.5%
27.0%
Guidance:
Consensus:
Endo Reaffirms

Endo International plc said it continues to expect 2016 earnings of $4.50 to $4.80 per share on revenue of $3.87 billion to $4.03 billion. The current consensus earnings estimate is $4.55 per share on revenue of $3.91 billion for the year ending December 31, 2016.
Date
Grade
Actual
Earnings
Whisper
Consensus
Estimate
Surprise
Growth
Gap
Drift
5/1/2014
6:00:00 AM
Mar '14
Q1 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C
EPS
Rev
$0.92
$594.61 Mil
$0.86
$0.84
$608.95 Mil
7.0%
-2.4%
-
-
6.0%
0.7%
7/31/2014
6:30:00 AM
Jun '14
Q2 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$1.06
$718.68 Mil
$0.94
$0.90
$645.91 Mil
12.8%
11.3%
-
-
1.9%
-10.6%
11/5/2014
7:00:00 AM
Sep '14
Q3 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C-
EPS
Rev
$1.15
$763.94 Mil
$1.03
$0.99
$725.71 Mil
11.7%
5.3%
-
-
2.0%
-3.1%
3/2/2015
7:00:00 AM
Dec '14
Q4 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$1.16
$799.96 Mil
$1.18
$1.13
$780.44 Mil
-1.7%
2.5%
-
-
2.2%
2.3%
5/11/2015
6:50:00 AM
Mar '15
Q1 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D
EPS
Rev
$1.17
$590.93 Mil
$1.09
$1.07
$716.25 Mil
7.3%
-17.5%
28.0%
-0.6%
1.3%
-8.4%
8/10/2015
6:30:00 AM
Jun '15
Q2 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G D+
EPS
Rev
$1.08
$735.17 Mil
$1.05
$1.02
$727.45 Mil
2.9%
1.1%
30.4%
2.3%
-4.1%
7.6%
11/5/2015
6:30:00 AM
Sep '15
Q3 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G C+
EPS
Rev
$1.02
$745.73 Mil
$1.02
$1.00
$736.16 Mil
-
1.3%
17.5%
-2.4%
-3.1%
-4.3%
2/29/2016
6:30:00 AM
Dec '15
Q4 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G B
EPS
Rev
$1.36
$1.1 Bil
$1.28
$1.27
$1.1 Bil
6.3%
0.3%
65.9%
34.2%
-4.7%
-11.7%
5/5/2016
4:05:00 PM
Mar '16
Q1 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A
EPS
Rev
$1.08
$963.54 Mil
-
$1.05
$956.80 Mil
2.9%
0.7%
40.3%
63.1%
-34.6%
-19.3%
8/8/2016
4:28:00 PM
Jun '16
Q2 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A-
EPS
Rev
$0.86
$920.89 Mil
-
$0.75
-
14.7%
-
-15.1%
25.3%
11.4%
13.1%
11/8/2016
6:30:00 AM
Sep '16
Q3 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G A
EPS
Rev
$1.01
$884.34 Mil
$0.84
$0.81
$867.01 Mil
20.2%
2.0%
5.3%
18.6%
-10.4%
27.0%
EPS
Rev
-
-
-
$1.63
$1.2 Bil
-
-
19.9%
7.1%
EPS
Rev
-
-
-
$1.50
$1.2 Bil
-
-
38.9%
23.5%
2/28/2011
$35.52
$3.48
$1.72 Bil
-
-
-
2/24/2012
$36.30
$4.69
$2.73 Bil
34.8%
59.1%
2.2%
2/28/2013
$31.00
$5.02
$3.03 Bil
7.0%
10.9%
-14.6%
2/28/2014
$79.82
$4.79
$2.62 Bil
-4.6%
-13.6%
157.5%
3/2/2015
$87.32
$4.31
$2.88 Bil
-10.0%
9.9%
9.4%
2/29/2016
$41.81
$4.87
$3.27 Bil
13.0%
13.6%
-52.1%
2/28/2017
$15.68
$4.56
$3.94 Bil
-6.4%
20.5%
-62.5%
2/28/2018
$46.21
$4.72
$4.03 Bil
3.5%
2.3%
194.7%
2/28/2019
-
$4.65
-
-1.5%
-
-

Price Projection

Current Value
$47
199%
Projected Price
$46
195%